Download our whitepaper,

"Improving Post-Operative Pain Clinical Trials:
Pivotal Endpoints, Failures, and Protocol Enhancements"

Post-Operative Pain Clinical Trials - iNGENū CRO

What's Inside:

  • Key FDA-Approved Pivotal Endpoints for Post-Operative Pain Clinical Trials.
  • Optimizing Recruitment with Adaptive Trial Designs for Post-Operative Pain.
  • Comprehensive Analysis of FDA-Approved Post-Operative Pain Drugs.
  • How Diagnostic Criteria for Post-Operative Pain Have Evolved and Impact Research.
  • Overcoming Common Pitfalls in Post-Operative Pain Clinical Trials.
  • And additional insights to drive your trial's success.

Access your complimentary whitepaper today:

Post-Operative Pain

Post-operative pain (POP) is a multifaceted condition that arises after surgical interventions, affecting nearly all patients to some degree.

The complexity of this type of pain is largely due to the interplay of various physiological and psychological factors. Acute pain typically manifests within hours of the surgery, peaking in intensity during the first 24-48 hours. Depending on the nature of the surgery and the patient's individual pain tolerance, it can last for days or weeks.

Effective post-operative pain management is essential for minimizing complications, enhancing recovery, and improving overall patient outcomes. Inadequately controlled pain can lead to chronic post-surgical pain (CPSP), which significantly impairs a patient's quality of life and increases healthcare costs.

At iNGENū, we are dedicated to advancing the understanding and treatment of Post-Operative Pain. Through cutting-edge research and a patient-centered approach, our mission is to deliver innovative solutions that improve the lives of individuals and families impacted by this challenging condition.

 

80%

of surgical patients experience acute post-operative pain

 

 

75%

of patients experiencing POP report it as moderate to severe

75.8% of emergency abdominal surgery patients experience moderate to sever pain in the first 

24h



Our clinical team has over

120

years of combined clinical trial experience